The effects of oxandrolone and exercise on muscle mass and function in children with severe burns

Rene Przkora, David Herndon, Oscar Suman

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

OBJECTIVES. Severe burns are associated with a significant loss of muscle and strength. Studies have reported that oxandrolone improves lean body mass in musclewasting conditions. Also shown previously in burned children is that an exercise program increases lean body mass and muscle strength. We hypothesized that oxandrolone, in combination with exercise, would increase lean body mass and muscle strength in severely burned children more than oxandrolone alone or exercise alone. METHODS AND PATIENTS. Fifty-one burned children (≥40% total body surface area burned) were randomly assigned to receive oxandrolone alone (0.1 mg/kg per day orally; n = 9), oxandrolone and exercise (n = 14), placebo and no exercise (n = 11), or placebo and exercise (n = 17). Administration of oxandrolone was started at discharge and continued until 1 year after burn. The 12-week exercise training program was started 6 months after burn. Serum hormones, lean body mass, muscle strength, and peak cardiopulmonary capacity were assessed at 6 (baseline) and 9 months after burn. Data were analyzed using a 1-way analysis of variance, and significance was set at P < .05. RESULTS. The mean percentage of change or increase in weight and lean body mass in the oxandrolone and exercise group was significant compared with placebo and exercise, as well as with the oxandrolone alone group or placebo and no exercise group. Furthermore, lean body mass was significantly improved in the oxandrolone and exercise, oxandrolone alone, and placebo and exercise group compared with the group only receiving placebo. Muscle strength significantly increased in oxandrolone and exercise, placebo and exercise, and the oxandrolone alone group when compared with the placebo and no exercise group. The peak cardiopulmonary capacity was significantly higher in both exercise groups. Insulin-like growth factor 1 was significantly increased in the oxandrolone alone group compared with placebo and exercise and placebo and no exercise. Both exercise groups showed significant changes in insulin-like binding-protein-3 when compared with groups without exercise.

Original languageEnglish (US)
JournalPediatrics
Volume119
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Oxandrolone
Burns
Exercise
Muscles
Placebos
Muscle Strength

Keywords

  • Burns
  • Exercise
  • Hormones
  • Lean mass
  • Oxandrolone

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

The effects of oxandrolone and exercise on muscle mass and function in children with severe burns. / Przkora, Rene; Herndon, David; Suman, Oscar.

In: Pediatrics, Vol. 119, No. 1, 01.2007.

Research output: Contribution to journalArticle

@article{13b40161218645b68a8140ec7105f250,
title = "The effects of oxandrolone and exercise on muscle mass and function in children with severe burns",
abstract = "OBJECTIVES. Severe burns are associated with a significant loss of muscle and strength. Studies have reported that oxandrolone improves lean body mass in musclewasting conditions. Also shown previously in burned children is that an exercise program increases lean body mass and muscle strength. We hypothesized that oxandrolone, in combination with exercise, would increase lean body mass and muscle strength in severely burned children more than oxandrolone alone or exercise alone. METHODS AND PATIENTS. Fifty-one burned children (≥40{\%} total body surface area burned) were randomly assigned to receive oxandrolone alone (0.1 mg/kg per day orally; n = 9), oxandrolone and exercise (n = 14), placebo and no exercise (n = 11), or placebo and exercise (n = 17). Administration of oxandrolone was started at discharge and continued until 1 year after burn. The 12-week exercise training program was started 6 months after burn. Serum hormones, lean body mass, muscle strength, and peak cardiopulmonary capacity were assessed at 6 (baseline) and 9 months after burn. Data were analyzed using a 1-way analysis of variance, and significance was set at P < .05. RESULTS. The mean percentage of change or increase in weight and lean body mass in the oxandrolone and exercise group was significant compared with placebo and exercise, as well as with the oxandrolone alone group or placebo and no exercise group. Furthermore, lean body mass was significantly improved in the oxandrolone and exercise, oxandrolone alone, and placebo and exercise group compared with the group only receiving placebo. Muscle strength significantly increased in oxandrolone and exercise, placebo and exercise, and the oxandrolone alone group when compared with the placebo and no exercise group. The peak cardiopulmonary capacity was significantly higher in both exercise groups. Insulin-like growth factor 1 was significantly increased in the oxandrolone alone group compared with placebo and exercise and placebo and no exercise. Both exercise groups showed significant changes in insulin-like binding-protein-3 when compared with groups without exercise.",
keywords = "Burns, Exercise, Hormones, Lean mass, Oxandrolone",
author = "Rene Przkora and David Herndon and Oscar Suman",
year = "2007",
month = "1",
doi = "10.1542/peds.2006-1548",
language = "English (US)",
volume = "119",
journal = "Pediatrics",
issn = "0031-4005",
publisher = "American Academy of Pediatrics",
number = "1",

}

TY - JOUR

T1 - The effects of oxandrolone and exercise on muscle mass and function in children with severe burns

AU - Przkora, Rene

AU - Herndon, David

AU - Suman, Oscar

PY - 2007/1

Y1 - 2007/1

N2 - OBJECTIVES. Severe burns are associated with a significant loss of muscle and strength. Studies have reported that oxandrolone improves lean body mass in musclewasting conditions. Also shown previously in burned children is that an exercise program increases lean body mass and muscle strength. We hypothesized that oxandrolone, in combination with exercise, would increase lean body mass and muscle strength in severely burned children more than oxandrolone alone or exercise alone. METHODS AND PATIENTS. Fifty-one burned children (≥40% total body surface area burned) were randomly assigned to receive oxandrolone alone (0.1 mg/kg per day orally; n = 9), oxandrolone and exercise (n = 14), placebo and no exercise (n = 11), or placebo and exercise (n = 17). Administration of oxandrolone was started at discharge and continued until 1 year after burn. The 12-week exercise training program was started 6 months after burn. Serum hormones, lean body mass, muscle strength, and peak cardiopulmonary capacity were assessed at 6 (baseline) and 9 months after burn. Data were analyzed using a 1-way analysis of variance, and significance was set at P < .05. RESULTS. The mean percentage of change or increase in weight and lean body mass in the oxandrolone and exercise group was significant compared with placebo and exercise, as well as with the oxandrolone alone group or placebo and no exercise group. Furthermore, lean body mass was significantly improved in the oxandrolone and exercise, oxandrolone alone, and placebo and exercise group compared with the group only receiving placebo. Muscle strength significantly increased in oxandrolone and exercise, placebo and exercise, and the oxandrolone alone group when compared with the placebo and no exercise group. The peak cardiopulmonary capacity was significantly higher in both exercise groups. Insulin-like growth factor 1 was significantly increased in the oxandrolone alone group compared with placebo and exercise and placebo and no exercise. Both exercise groups showed significant changes in insulin-like binding-protein-3 when compared with groups without exercise.

AB - OBJECTIVES. Severe burns are associated with a significant loss of muscle and strength. Studies have reported that oxandrolone improves lean body mass in musclewasting conditions. Also shown previously in burned children is that an exercise program increases lean body mass and muscle strength. We hypothesized that oxandrolone, in combination with exercise, would increase lean body mass and muscle strength in severely burned children more than oxandrolone alone or exercise alone. METHODS AND PATIENTS. Fifty-one burned children (≥40% total body surface area burned) were randomly assigned to receive oxandrolone alone (0.1 mg/kg per day orally; n = 9), oxandrolone and exercise (n = 14), placebo and no exercise (n = 11), or placebo and exercise (n = 17). Administration of oxandrolone was started at discharge and continued until 1 year after burn. The 12-week exercise training program was started 6 months after burn. Serum hormones, lean body mass, muscle strength, and peak cardiopulmonary capacity were assessed at 6 (baseline) and 9 months after burn. Data were analyzed using a 1-way analysis of variance, and significance was set at P < .05. RESULTS. The mean percentage of change or increase in weight and lean body mass in the oxandrolone and exercise group was significant compared with placebo and exercise, as well as with the oxandrolone alone group or placebo and no exercise group. Furthermore, lean body mass was significantly improved in the oxandrolone and exercise, oxandrolone alone, and placebo and exercise group compared with the group only receiving placebo. Muscle strength significantly increased in oxandrolone and exercise, placebo and exercise, and the oxandrolone alone group when compared with the placebo and no exercise group. The peak cardiopulmonary capacity was significantly higher in both exercise groups. Insulin-like growth factor 1 was significantly increased in the oxandrolone alone group compared with placebo and exercise and placebo and no exercise. Both exercise groups showed significant changes in insulin-like binding-protein-3 when compared with groups without exercise.

KW - Burns

KW - Exercise

KW - Hormones

KW - Lean mass

KW - Oxandrolone

UR - http://www.scopus.com/inward/record.url?scp=33846926847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846926847&partnerID=8YFLogxK

U2 - 10.1542/peds.2006-1548

DO - 10.1542/peds.2006-1548

M3 - Article

VL - 119

JO - Pediatrics

JF - Pediatrics

SN - 0031-4005

IS - 1

ER -